CYCLO THERAPEUTICS INC
NASDAQ: CYTHW (Cyclo Therapeutics, Inc.)
Kemas kini terakhir: 19 jam lalu0.032
0.00 (0.00%)
| Penutupan Terdahulu | 0.032 |
| Buka | 0.070 |
| Jumlah Dagangan | 28,412 |
| Purata Dagangan (3B) | 12,317 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -3,545.95% |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -52.80% |
| Nisbah Semasa (MRQ) | 0.170 |
| Aliran Tunai Operasi (OCF TTM) | -22.52 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -13.05 M |
| Pulangan Atas Aset (ROA TTM) | -284.27% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Menaik |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Bercampur | |
| Stok | Cyclo Therapeutics, Inc. | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | NA |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 0.0 |
| Purata | 0.00 |
|
Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of neurodegenerative diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo that is in Phase IIb clinical trials for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |